Camilo Martinez, a former analyst for biotechnology at Pequot Capital Management who departed from the firm earlier this year, has resurfaced on the West Coast. Martinez is planning the launch of a long/short equity fund focused on healthcare. The fund, which may be called CM Biomedical Fund, is slated for a July 1 launch. Martinez's fund will invest primarily in small-cap companies.
At Pequot, Martinez served as the biotechnology and genomics sector equity analyst advising portfolio managers on the long and short biotechnology positions of its dedicated healthcare fund and other diversified portfolios.
Prior to Pequot, Martinez was a